This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Company News for Aug 13, 2021
by Zacks Equity Research
Companies In The News Are: CSIQ, DDS, EYE, AZEK
Dillard's (DDS) Rises as Q2 Earnings & Sales Beat Estimates
by Zacks Equity Research
Dillard's (DDS) Q2 results benefit from strong consumer demand and a focus on inventory and expense management.
Dillard's (DDS) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Dillard's (DDS) delivered earnings and revenue surprises of 259.59% and 24.83%, respectively, for the quarter ended July 2021. Do the numbers hold clues to what lies ahead for the stock?
Here's How Dillard's (DDS) is Positioned Ahead of Q2 Earnings
by Zacks Equity Research
Vaccination drives and the lifting of restrictions on movement are expected to have aided a recovery in consumer demand and store traffic trends, driving Dillard's (DDS) Q2 earnings.
Dillard's (DDS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Dillard's (DDS) closed at $174.93 in the latest trading session, marking a +1.74% move from the prior day.
Dillard's (DDS) Earnings Expected to Grow: What to Know Ahead of Q2 Release
by Zacks Equity Research
Dillard's (DDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dillard's (DDS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Dillard's (DDS) closed at $181.81 in the latest trading session, marking a -0.89% move from the prior day.
Dillard's (DDS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Dillard's (DDS) closed at $182.26 in the latest trading session, marking a -1.53% move from the prior day.
Dillard's (DDS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Dillard's (DDS) closed at $185.10, marking a +1.13% move from the previous day.
Should Value Investors Buy Dillard's (DDS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Dillards (DDS) Outperforming Other Retail-Wholesale Stocks This Year?
by Zacks Equity Research
Is (DDS) Outperforming Other Retail-Wholesale Stocks This Year?
Why You Shouldn't Bet Against Dillard's (DDS) Stock
by Aditi Saraogi
Dillard's (DDS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Dillard's (DDS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Dillard's (DDS) closed the most recent trading day at $186.80, moving +1.72% from the previous trading session.
Why Dillard's (DDS) is a Great Investment Option at the Moment
by Zacks Equity Research
Dillard's (DDS) is poised to retain momentum on recovery in store traffic and consumer demand. Gains from inventory and cost-management strategies will continue to be drivers.
Zacks.com featured highlights include: Dillard's, Target, Herc Holdings and Echo Global Logistics
by Zacks Equity Research
Zacks.com featured highlights include: Dillard's, Target, Herc Holdings and Echo Global Logistics
4 Stocks That Boast Impressive Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Companies such as Dillard's (DDS), Target (TGT), Herc (HRI) and Echo Global (ECHO) are sound enough to meet financial obligations.
The Zacks Analyst Blog Highlights: American Axle & Manufacturing, Conn's, Dillards, Zoom and KornFerry
by Zacks Equity Research
The Zacks Analyst Blog Highlights: American Axle & Manufacturing, Conn's, Dillards, Zoom and KornFerry
Dillard's (DDS) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Dillard's, Inc. (DDS).
5 Top-Ranked Growth Stocks to Own in Second-Half 2021
by Tirthankar Chakraborty
With the stock market poised to maintain performance in the second half of the year, it's worth placing bets on growth stocks like Conns (CONN), Dillards (DDS) & Zoom Video (ZM) at the moment.
Kohl's (KSS) Poised on Robust Online Business & Partnerships
by Zacks Equity Research
Kohl's (KSS) is benefiting from its growing digital business, especially amid the pandemic. Also, the company's prudent partnerships are worth mentioning.
Top Ranked Momentum Stocks to Buy for July 2nd
by Zacks Equity Research
DDS, MGY, CLR, and DIOD made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 2, 2021.
Zacks.com featured highlights include: Vale, Smith & Wesson, GMS and Dillard's
by Zacks Equity Research
Zacks.com featured highlights include: Vale, Smith & Wesson, GMS and Dillard's
Want to Bet on Relative Price Strength? Try These 4 Stocks
by Nilanjan Choudhury
Vale (VALE), Smith & Wesson Brands (SWBI), GMS (GMS) and Dillard's (DDS) are four stocks with explosive relative price strength.
Best Stocks From Top Wall Street Stories of First Half
by Sweta Killa
We present some of the events that dominated the headlines in the first half and their best stocks such as Dillards (DDS), BuildABear (BBW), Aemetis (AMTX), Alcoa (AA), GameStop (GME) and Generac (GNRC).
3 Reasons Growth Investors Will Love Dillard's (DDS)
by Zacks Equity Research
Dillard's (DDS) is well positioned to outperform the market, as it exhibits above-average growth in financials.